A product of independent beta probabilities dose escalation design for dual‐agent phase I trials

DOI10.1002/SIM.6434MaRDI QIDQ153908WikidataFDO

Authors Adrian Paul Mander, Michael J. Sweeting

Publication date 29 January 2015

Published in Statistics in Medicine (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1002/SIM.6434

Cited in

(1)

• pipe.design

This page was built for publication: A product of independent beta probabilities dose escalation design for dual‐agent phase I trials

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q153908)